Lesley Scott

The patient impact of point-of-care vs. laboratory placement of Xpert(®) MTB/RIF.

L. Scott, I. Sanne, W. Stevens, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.

J. Bassett, L. Page-Shipp, H. Dansey, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study

S. Dorman, D. Alland, S. Chakravorty, 2018, The Lancet. Infectious diseases.